日本語 
Biotech
Japan continues its effort to solidify its status as a leader in innovation through the adoption of artificial intelligence (AI), digital transformation (DX), and research in healthcare, education, pharmacy, and…
Shonan iPark and LabCentral Forge Strategic Partnership to Propel Asian Biotech Startups into U.S. Ecosystem
Shonan iPark, a leading life sciences hub in Japan, has teamed up…
Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan’s Biotech and Tech Industries
In October 2025, Novo Nordisk, a Danish pharma company, announced it will…
UK and Japan Forge Strategic Biotech Alliance to Propel Innovation
The UK BioIndustry Association (BIA) is joining forces with the Japan Bioindustry…
Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth
Celaid Therapeutics Inc. announced that it successfully completed the first close of…
Hinge Bio partners with Kyorin to Develop HB2198 in Japan
Hinge Bio, Inc., a private biotech firm that focuses on multispecific antibody…
Celaid Therapeutics and AGC sign iPSC-HSPC research deal
Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…
Asahi Kasei Opens New Plant to Boost Planova Output
Asahi Kasei Life Science will build a new spinning plant in Nobeoka…
Pahr Therapeutics secures $14M to develop PAH therapies
Pahr Therapeutics has raised $14 million in seed funding. This money will…
Shonan iPark and LabCentral Forge Strategic Partnership to Propel Asian Biotech Startups into U.S. Ecosystem
Shonan iPark, a leading life sciences hub in Japan, has teamed up…
Novo Nordisk Acquires Akero Therapeutics for Up to US$ 5.2 Billion: Implications for Japan’s Biotech and Tech Industries
In October 2025, Novo Nordisk, a Danish pharma company, announced it will…
UK and Japan Forge Strategic Biotech Alliance to Propel Innovation
The UK BioIndustry Association (BIA) is joining forces with the Japan Bioindustry…
Celaid Therapeutics Raises ¥1.05B for Stem Cell Growth
Celaid Therapeutics Inc. announced that it successfully completed the first close of…
Hinge Bio partners with Kyorin to Develop HB2198 in Japan
Hinge Bio, Inc., a private biotech firm that focuses on multispecific antibody…
Celaid Therapeutics and AGC sign iPSC-HSPC research deal
Celaid Therapeutics Inc. Celaid has teamed up with AGC Inc. for a…
Asahi Kasei Opens New Plant to Boost Planova Output
Asahi Kasei Life Science will build a new spinning plant in Nobeoka…
Pahr Therapeutics secures $14M to develop PAH therapies
Pahr Therapeutics has raised $14 million in seed funding. This money will…
English